Aflatoxin M1 Test

Some of the most dangerous substances you can eat are completely invisible. Aflatoxin B1, produced by common molds that grow on grains, corn, peanuts, and other staple foods, is one of the most potent natural cancer-causing compounds known. When you eat contaminated food, your liver converts aflatoxin B1 into aflatoxin M1 (AFM1), and your body excretes it in urine. This test measures that urinary AFM1, giving you a direct readout of whether aflatoxin is getting into your system.

The value of knowing your level is straightforward: chronic aflatoxin exposure raises your risk of liver cancer, especially if you also carry hepatitis B. Yet most people have no idea whether they are exposed. A study of over 18,000 men in Shanghai found detectable urinary aflatoxin markers in nearly half of them. Populations across Africa, South Asia, the Middle East, and Latin America show similarly widespread exposure. If you eat grains, nuts, rice, or dairy, and especially if those foods come from supply chains with limited mold-control infrastructure, this test tells you something a standard blood panel never will.

How Aflatoxin B1 Becomes Aflatoxin M1

Aflatoxin B1 (AFB1) is a toxin produced by Aspergillus molds, which thrive on crops stored in warm, humid conditions. After you eat food containing AFB1, your liver's detoxification enzymes (part of the cytochrome P450 family) convert it into several breakdown products. One of these is AFM1, a smaller, water-soluble molecule that your kidneys filter into urine. Mammals excrete roughly 0.3% to 6.3% of ingested AFB1 as AFM1.

AFM1 is not harmless. While it is somewhat less toxic than its parent compound, it is classified by the International Agency for Research on Cancer (IARC) as possibly carcinogenic to humans (Group 2B). Its parent compound AFB1, along with naturally occurring aflatoxin mixtures, carries the higher Group 1 (carcinogenic to humans) classification. AFM1 can damage DNA and injure liver cells, and animal studies suggest it can also suppress immune function. Because it is heat-stable, cooking or pasteurizing contaminated food does not eliminate the risk.

Liver Cancer Risk

The most studied health consequence of aflatoxin exposure is liver cancer, specifically a type called hepatocellular carcinoma (HCC). A landmark follow-up study of over 18,000 men in Shanghai found that those with detectable urinary aflatoxin markers had elevated liver cancer risk. The connection is strongest in people who also carry chronic hepatitis B virus (HBV) infection.

In a study of 145 male chronic hepatitis B carriers in Qidong, China, those with detectable urinary AFM1 had about 3.3 times the risk of developing liver cancer compared to carriers without detectable AFM1. A study within a larger health survey in Taiwan found that higher aflatoxin biomarker levels were associated with higher liver cancer risk among chronic HBV carriers, and that inherited differences in detoxification enzymes (specifically GSTM1 and GSTT1 gene variants) further modified that risk.

For people without hepatitis B, the absolute cancer risk from AFM1 at typical dietary exposure levels is small. Population modeling across Italy, Serbia, Albania, and Ethiopia consistently estimates fewer than 0.01 additional liver cancer cases per 100,000 people per year at average exposure. But risk is not zero, and it rises in regions where contamination is high and hepatitis is common.

Diabetes and Metabolic Risk

Emerging evidence links aflatoxin exposure to metabolic problems beyond the liver. A study of 672 adults found that those with higher urinary AFM1 levels had elevated markers of inflammation, oxidative stress (a form of cellular damage from unstable molecules), and impaired insulin signaling, all of which are precursors to type 2 diabetes. This is observational evidence, not proof of causation, but it suggests aflatoxin exposure may contribute to metabolic dysfunction over time.

Pregnancy and Child Health

Infants and young children face the highest relative exposure because they consume more food per kilogram of body weight. Risk assessments across Serbia, Iran, Kenya, Albania, and India consistently show that toddlers and children aged one to three have estimated daily intakes two to ten times higher than adults eating from the same food supply.

A meta-analysis of aflatoxin exposure during pregnancy in Africa found that about three out of five pregnant women had detectable exposure, and this was associated with prematurity, low birthweight, and small-for-gestational-age births. Evidence on whether AFM1 specifically impairs child growth through dairy consumption is currently mixed and inconclusive, with studies pointing in different directions.

When Results Can Be Misleading

Urinary AFM1 reflects recent dietary exposure, typically within the past 24 to 48 hours. A single reading can be heavily influenced by what you ate in the day or two before the test. If you happened to consume a meal with unusually high or low contamination, that single sample may not represent your typical exposure pattern.

• Hydration matters. A very dilute urine sample (from drinking large amounts of water) can produce a falsely low reading, while a concentrated sample can push the number higher. Some labs correct for this by adjusting the result based on how concentrated the sample is (a method called creatinine normalization), but not all do.
• Timing of the sample relative to your last meal affects results. AFM1 peaks in urine several hours after eating contaminated food and drops as the toxin clears.
• Seasonal variation in food contamination means results can differ between summer (higher mold growth) and winter, even if your diet stays the same.
• No specific medications are known to falsely raise or lower urinary AFM1. The number reflects actual toxin exposure, not a drug interaction.

Understanding Your Results

There are no standardized clinical reference ranges for urinary AFM1. This is an exposure biomarker used primarily in research and population surveillance, not a routine clinical test with established "normal" and "abnormal" cutpoints. Your lab will report a concentration, typically in nanograms per liter or similar units, but there is no universally agreed threshold that separates "safe" from "unsafe."

Regulators treat aflatoxins as substances where no exposure level is considered completely without risk. The European Union sets a maximum limit of 50 ng/kg for AFM1 in milk and 25 ng/kg in infant formula, but these are food safety limits, not human body-fluid targets. Researchers use risk metrics like the Hazard Index (HI), where a value above 1 signals concern, and the Margin of Exposure (MOE), where a value below 10,000 signals potential concern. These calculations require knowing your estimated daily intake, not just a single urine concentration.

In practical terms, any detectable urinary AFM1 confirms that aflatoxin is reaching your body. A higher reading means greater recent exposure. Because this is a research-grade exposure marker without consensus clinical cutpoints, the most useful approach is to track your level over time within the same lab rather than trying to match a single result to a fixed threshold.

Tracking Your Trend

A single urinary AFM1 reading is a snapshot of the past day or two. It tells you whether aflatoxin reached your body recently, but it cannot distinguish a one-time exposure from a chronic pattern. Serial testing is the only way to separate the two.

If your first result shows detectable AFM1, consider retesting in two to four weeks. If the level is consistently detectable across multiple samples taken at different times, that pattern suggests ongoing dietary exposure rather than an isolated event. If you make changes to your food sourcing, retesting after four to eight weeks can show whether those changes are actually reducing the toxin reaching your body.

Because aflatoxin contamination in food varies by season, testing at least twice a year (once in warmer months when mold growth peaks, once in cooler months) gives you the most complete picture. Compare results within the same lab, since different assay methods can produce different numbers for the same sample.

What to Do With Your Results

If your urinary AFM1 is undetectable or very low, that is reassuring but not a permanent guarantee. Your exposure depends on your food supply, which can change with season, sourcing, and storage conditions.

If AFM1 is consistently detectable, the first step is to identify the likely food sources. Grains (especially corn and rice), peanuts, tree nuts, spices, and dairy products from regions with poor mold control are the most common culprits. Switching to food sources from supply chains with stricter aflatoxin monitoring may reduce your exposure.

If you carry chronic hepatitis B or C, detectable urinary AFM1 takes on added significance, since the combination of aflatoxin exposure and viral hepatitis multiplies liver cancer risk. In that case, share your results with a hepatologist or liver specialist, who may recommend more frequent liver imaging and alpha-fetoprotein (AFP, a blood marker used to screen for liver cancer) monitoring.

For anyone with detectable results, ordering a liver function panel (including ALT, AST, and GGT, enzymes that signal liver stress) alongside repeat AFM1 testing can help determine whether exposure is causing measurable liver effects. The full mycotoxins panel, which tests for other mold-produced toxins like ochratoxin A and zearalenone, provides a broader picture of your total mycotoxin burden.